中华外科杂志
中華外科雜誌
중화외과잡지
CHINESE JOURNAL OF SURGERY
2012年
7期
650-654
,共5页
杨帆%胡耑%白祥军%张锟%李仁杰%薛晨晨
楊帆%鬍耑%白祥軍%張錕%李仁傑%薛晨晨
양범%호단%백상군%장곤%리인걸%설신신
负压伤口疗法%新生血管化,病理性%缺氧诱导因子1,α亚基%血管内皮生长因子A
負壓傷口療法%新生血管化,病理性%缺氧誘導因子1,α亞基%血管內皮生長因子A
부압상구요법%신생혈관화,병이성%결양유도인자1,α아기%혈관내피생장인자A
Negative-pressure wound therapy%Neovascularization,pathologic%Hypoxia-inducible factor 1,dpha subunit%Vascular endothelial growth factor A
目的 观察负压封闭引流(VSD)技术对兔创面模型局部氧分压(PtO2)变化和新生毛细血管(NBC)形成的影响.方法 建立12只兔创面模型,实施VSD手术(负压组),于7d内各时间点用组织氧分压测量仪监测创面PtO2变化;以实时荧光PCR法检测创面低氧诱导因子1α(HIF-1α)mRNA的表达;以ELISA法检测创面血管内皮生长因子(VEGF)的含量;通过光镜观察血管内皮细胞(VEC)和NBC并计数.设立常规换药实验兔(常规组)进行对照.结果 建模后负压组PtO2较常规组显著降低(t=-99.780~ -5.305,P<0.01).自30 min起负压组的HIF-1αmRNA表达(30 min,1、6、12 h分别为3.11±0.07、3.68±0.26、4.16±0.13和3.91±0.26)和VEGF含量(pg/L) (30 min,1、6、12 h分别为103.3±2.4、134.2±9.0、167.8±3.8和232.1±9.5)较常规组显著升高(t=13.038~80.208,P<0.01).1d后两组HIF-1α mRNA表达和VEGF含量均开始下调,但负压组仍持续高于常规组(P<0.05),同时负压组的创面VEC(2.47±0.45 ~4.70±0.38)和NBC计数(1.33±0.49~4.33±0.68)较常规组升高(t=-0.670 ~ 16.500,P<0.05).结论 VSD技术可通过降低创面Pt02、上调HIF-1α mRNA的表达,促进VEGF的合成,增加VEC的分化和NBC的形成,有利于创面愈合.
目的 觀察負壓封閉引流(VSD)技術對兔創麵模型跼部氧分壓(PtO2)變化和新生毛細血管(NBC)形成的影響.方法 建立12隻兔創麵模型,實施VSD手術(負壓組),于7d內各時間點用組織氧分壓測量儀鑑測創麵PtO2變化;以實時熒光PCR法檢測創麵低氧誘導因子1α(HIF-1α)mRNA的錶達;以ELISA法檢測創麵血管內皮生長因子(VEGF)的含量;通過光鏡觀察血管內皮細胞(VEC)和NBC併計數.設立常規換藥實驗兔(常規組)進行對照.結果 建模後負壓組PtO2較常規組顯著降低(t=-99.780~ -5.305,P<0.01).自30 min起負壓組的HIF-1αmRNA錶達(30 min,1、6、12 h分彆為3.11±0.07、3.68±0.26、4.16±0.13和3.91±0.26)和VEGF含量(pg/L) (30 min,1、6、12 h分彆為103.3±2.4、134.2±9.0、167.8±3.8和232.1±9.5)較常規組顯著升高(t=13.038~80.208,P<0.01).1d後兩組HIF-1α mRNA錶達和VEGF含量均開始下調,但負壓組仍持續高于常規組(P<0.05),同時負壓組的創麵VEC(2.47±0.45 ~4.70±0.38)和NBC計數(1.33±0.49~4.33±0.68)較常規組升高(t=-0.670 ~ 16.500,P<0.05).結論 VSD技術可通過降低創麵Pt02、上調HIF-1α mRNA的錶達,促進VEGF的閤成,增加VEC的分化和NBC的形成,有利于創麵愈閤.
목적 관찰부압봉폐인류(VSD)기술대토창면모형국부양분압(PtO2)변화화신생모세혈관(NBC)형성적영향.방법 건립12지토창면모형,실시VSD수술(부압조),우7d내각시간점용조직양분압측량의감측창면PtO2변화;이실시형광PCR법검측창면저양유도인자1α(HIF-1α)mRNA적표체;이ELISA법검측창면혈관내피생장인자(VEGF)적함량;통과광경관찰혈관내피세포(VEC)화NBC병계수.설립상규환약실험토(상규조)진행대조.결과 건모후부압조PtO2교상규조현저강저(t=-99.780~ -5.305,P<0.01).자30 min기부압조적HIF-1αmRNA표체(30 min,1、6、12 h분별위3.11±0.07、3.68±0.26、4.16±0.13화3.91±0.26)화VEGF함량(pg/L) (30 min,1、6、12 h분별위103.3±2.4、134.2±9.0、167.8±3.8화232.1±9.5)교상규조현저승고(t=13.038~80.208,P<0.01).1d후량조HIF-1α mRNA표체화VEGF함량균개시하조,단부압조잉지속고우상규조(P<0.05),동시부압조적창면VEC(2.47±0.45 ~4.70±0.38)화NBC계수(1.33±0.49~4.33±0.68)교상규조승고(t=-0.670 ~ 16.500,P<0.05).결론 VSD기술가통과강저창면Pt02、상조HIF-1α mRNA적표체,촉진VEGF적합성,증가VEC적분화화NBC적형성,유리우창면유합.
Objective To investigate the effect of vacuum sealing drainage (VSD) on variation of oxygen partial pressure ( PtO2 ) and vascularization.Methods The 12 cases of rabbit's wound models were undergoing the VSD ( vacuum group,n =6) or conventional therapy ( conventional group,n =6).Variation of PtO2 was measured by oxygen partial pressure admeasuring apparatus,expression of hypoxia inducible factor 1α (HIF-1α) mRNA was measured by real-time fluorescent quantitative PCR,content of vascular endothelial growth factor (VEGF) was measured by ELISA after tissue homogenate in 7 days.Vascular endothelial cell (VEC) and new blood capillary (NBC) of hematoxylin-eosin slice of tissue were counted by using light microscope.Results Average value of PtO2 of vacuum group was significant lower than conventional group (t=-99.780 to -5.305,P<0.01).Expression of HIF-1α (30 minutes,1,6,12 hours were 3.11 ±0.07,3.68 ±0.26,4.16 ±0.13 and 3.91 ±0.26 respectively) and content of VEGF (30 minutes,1,6,12 hours were 103.3 ±2.4,134.2 ±9.0,167.8 ±3.8 and 232.1 ±9.5 respectively)of vacuum group were increased after 30 minutes and significant lower than conventional group ( t =13.038-80.208,P <0.01 ),and both of them were reduced after 24 hours (P <0.05 ).Counting numbers of VEC (2.47 ± 0.45 to 4.70 ± 0.38 ) and NBC ( 1.33 ± 0.49 to 4.33 ± 0.68 ) of vacuum group were increased at the same time-point and significant higher than conventional group ( t =- 0.670 to 16.500,P < 0.05 ).Conclusions PtO2 of wound surface could be reduced significantly by VSD.Expression of HIF-1α and content of VEGF were increased by VSD for enhancing differentiated state of VEC and construction of NBC,which were better for vascularization and wound healing.